Related Experiment Videos
Signal transduction pathways in cerebral vasospasm.
Alexander Y. Zubkov1, Anil Nanda, John H. Zhang
1Department of Neurology, University of Mississippi Medical Center, Jackson, MS, USA
Summary
Cerebral vasospasm, a dangerous complication of ruptured aneurysms, is difficult to treat due to its delayed onset and resistance to vasodilators. Targeting signaling pathways may offer new selective treatments for this condition.
Area of Science:
- Neurology
- Vascular Surgery
- Pharmacology
Background:
- Cerebral vasospasm is a life-threatening complication following subarachnoid hemorrhage from ruptured intracranial aneurysms.
- It is characterized by a slow onset (4-7 days peak) and prolonged duration (2-3 weeks), often proving resistant to conventional vasodilators.
- Vasospasm significantly impacts patient outcomes after subarachnoid hemorrhage.
Purpose of the Study:
- To review the unique characteristics of cerebral vasospasm.
- To discuss current treatment strategies for cerebral vasospasm.
- To explore emerging experimental treatments targeting signaling pathways.
Main Methods:
- Literature review of cerebral vasospasm.
- Analysis of current therapeutic interventions.
- Discussion of novel experimental approaches.
Main Results:
- Cerebral vasospasm presents a unique and challenging clinical profile.
- Existing treatments like angioplasty and calcium channel blockers have limitations.
- Signaling pathways represent a promising new target for selective vasospasm treatment.
Conclusions:
- Understanding the signaling pathways involved in cerebral vasospasm is crucial.
- Targeting these pathways may lead to more selective and effective future therapies.
- This approach holds potential for improving outcomes in patients with subarachnoid hemorrhage.